Characterization of homogeneously staining regions in a small cell lung cancer cell line, using in situ hybridization with an MYCN probe
β Scribed by Erin Dietzsch; Robyn E. Lukeis; Vickie Vrazas; Suzanne Hasthorpe; Dr. O. Margaret Garson
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 338 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
The cell line CIPL38 was derived from the pleural effusion of a patient with small cell lung cancer. The karyotype was hyperdiploid and complex with a variable number of marker chromosomes. Two of the markers had large homogeneously staining regions (hsr), which were shown to consist of amplified MYCN by in situ hybridization. One hsr bearing a marker chromosome could not be identified with Gβbanding, but the other was situated on a der(14). This was elucidated further with FISH analysis, which enabled the identification of sequences of chromosome I involved in a complex rearrangement with chromosome 14 and the hsr. Genes Chromosom Cancer 10:213β216 (1994). Β© 1994 WileyβLiss, Inc.
π SIMILAR VOLUMES
## Background: Immunoreactivity for chromogranin a (cg a) is associated with the presence of neurosecretory granules in tumor cells, but immunohistochemical staining for cg a may be absent in small cell lung carcinoma (sclc), which has only a few secretory granules. localization of cg a mrna is a u
W e read with great interest the article by Sumiyoshi et al., 1 in which the authors report that the detection of chromogranin A (Cg A) mRNA using a new in situ hybridization method is far more sensitive than immunohistochemistry. In their series, 100% of 20 small cell carcinoma (SCLC) cases were po
Chromosomal homogeneous staining region (hsr), which is a cytogenetic indication of gene amplification, was found in the pleural effusion (BHII) of a patient with small cell lung cancer (SCLC) after failure of multiple drug treatments. Amplification of band I I q I 3 was identified as the origin of
To generate non-small cell lung cancer (NSCLC)-reactive lymphocytes, we transfected an HLA-A2-expressing human NSCLC line (1355) with the cDNA encoding the lymphocyte co-stimulatory molecule CD80. Following selection in G418, 1355.7 demonstrated stable cell-surface expression of CD80. Allogeneic mix
The sole chromosome defect in a colon cancer cell line derived from a patient with inherited nonpolyposis colorectal cancer was karyotypically designated as 46,XY,-I3,+der( I3)t( I; I3)(q32. I ;p I I) on the basis of banding homology. We have obtained molecular confirmation that the additional chrom